- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
ZIM Laboratories' Board approved consolidated Q1FY27 results. Revenue from operations stood at ₹94.18 Cr, with the company reporting a net loss of ₹4.02 Cr for the quarter ended June 30, 2026.